CIK 0000907654
- Non-accelerated filer
- Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363855489
- Phone
- +1 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- 4 Open-market sale 10% owner sold 1,460,209 shares at $0.50 ($731,273)
- 4 Open-market sale 10% owner sold 1,460,209 shares at $0.50 ($731,273)
- 4 Open-market sale 10% owner sold 1,460,209 shares at $0.50 ($731,273)
- 4 Open-market sale 10% owner sold 1,460,209 shares at $0.50 ($731,273)
- 4 Open-market sale 10% owner sold 1,460,209 shares at $0.50 ($731,273)
- 4 Open-market sale 10% owner sold 1,460,209 shares at $0.50 ($731,273)
- 4 Open-market sale 10% owner sold 1,460,209 shares at $0.50 ($731,273)
- 4 Open-market sale 10% owner sold 1,460,209 shares at $0.50 ($731,273)
- 4 Open-market buy Director bought 10,000 shares at $2.49 ($24,900)
- 4 Open-market buy Director bought 11,000 shares at $2.71 ($29,810)
- 4 Open-market sale VP, Finance sold 1,114 shares at $2.46 ($2,740)
- 4 Open-market sale S.V.P., General Counsel sold 418 shares at $2.41 ($1,007)
- 4 Open-market sale Chief Operating Officer sold 390 shares at $2.41 ($940)
- 4 Open-market sale Pres. & Chief Executive Offic sold 720 shares at $2.41 ($1,735)
- 4 Open-market buy Director bought 25,000 shares at $2.59 ($64,750)
- 4 Open-market sale VP, Finance sold 161 shares at $2.56 ($412)
- 4 Open-market sale S.V.P., General Counsel sold 465 shares at $2.61 ($1,214)
- 4 Open-market sale Chief Operating Officer sold 465 shares at $2.61 ($1,214)
- 4 Open-market sale Pres. & Chief Executive Offic sold 763 shares at $2.61 ($1,991)
- 4 Derivatives Options or other derivatives
Page 9 of 23 · 459 filings